Realm Therapeutics (RLM)

Sector:

Health Care

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 8.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.00p
  • 52 Week Low: 8.25p
  • Currency: UK Pounds
  • Shares Issued: 116.56m
  • Volume: 0
  • Market Cap: £9.62m
  • Beta: 0.35

RLM Overview

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

Key Personnel

CEO and Executive director: Alex Martin
CFO and COO: Marella Thorell
Chief Medical Officer: Christian Peters
Non-Executive Chairman: Charles Spicer
Senior Independent Non-Executive Director: Joseph William Birkett
Non-Executive Dir: Balkrishan (Simba) Gill, Ivan Gergel, Sanford Zweifach

Contact Details

Address: Cannon Place, 78 Cannon Street, London, EC4N 6AF
Phone: +44 (0) 20 7509 9900
Fax: +44 (0) 20 7509 9600
Website: www.realmtx.com

Listings

Sector: Health Care(LSE)
ISIN: GB00B3XBCR18

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

RLM Market Data

Currency UK Pounds
Share Price 8.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.00p
52 Week Low 8.25p
Volume 0
Shares Issued 116.56m
Market Cap £9.62m
Beta 0.35

RLM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.27% above the market average66.27% above the market average66.27% above the market average66.27% above the market average66.27% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Price Trend
95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average
Income Not Available
Growth
25.51% below the market average25.51% below the market average25.51% below the market average25.51% below the market average25.51% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average

RLM Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

Top of Page